Paper31333656
Reactivating Immunity Primed by Acellular Pertussis Vaccines in the Absence of Circulating Antibodies: Enhanced Bacterial Control by TLR9 Rather Than TLR4 Agonist-Including Formulation.
Auderset F and 11 others. Front Immunol, 2019. Cited by 15 papers, by iCite.
Cite this record
ConductScience Library. Reactivating Immunity Primed by Acellular Pertussis Vaccines in the Absence of Circulating Antibodies: Enhanced Bacterial Control by TLR9 Rather Than TLR4 Agonist-Including Formulation. Papers, record 31333656. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31333656
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Reactivating Immunity Primed by Acellular Pertussis Vaccines in the Absence of Circulating Antibodies: Enhanced Bacterial Control by TLR9 Rather Than TLR4 Agonist-Including Formulation.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adjuvants, Immunologic | Major topic |
| Bordetella pertussis | Major topic |
| Pertussis Vaccine | Major topic |
| Toll-Like Receptor 4 | Major topic |
| Toll-Like Receptor 9 | Major topic |
| Animals | |
| Antibodies, Bacterial | |
| Female | |
| Mice | |
| Mice, Inbred BALB C | |
| Whooping Cough |
Source PubMed
References62
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10417175 | Cell-mediated immune responses in four-year-old children after primary immunization with acellular pertussis vaccines. | Infect Immun | 1999 | https://conductscience.org/library/papers/10417175 | PubMed |
| 2 | 10837200 | Protection against Bordetella pertussis in mice in the absence of detectable circulating antibody: implications for long-term immunity in children. | J Infect Dis | 2000 | https://conductscience.org/library/papers/10837200 | PubMed |
| 3 | 11445452 | Immunity to Bordetella pertussis. | Microbes Infect | 2001 | https://conductscience.org/library/papers/11445452 | PubMed |
| 4 | 11750224 | CpG ODN can re-direct the Th bias of established Th2 immune responses in adult and young mice. | FEMS Immunol Med Microbiol | 2001 | https://conductscience.org/library/papers/11750224 | PubMed |
| 5 | 12385032 | Bordetella pertussis toxin induces the release of inflammatory cytokines and dendritic cell activation in whole blood: impaired responses in human newborns. | Eur J Immunol | 2002 | https://conductscience.org/library/papers/12385032 | PubMed |
| 6 | 12467690 | Pertussis of adults and infants. | Lancet Infect Dis | 2002 | https://conductscience.org/library/papers/12467690 | PubMed |
| 7 | 12538714 | Bordetella pertussis infection in 2-month-old infants promotes type 1 T cell responses. | J Immunol | 2003 | https://conductscience.org/library/papers/12538714 | PubMed |
| 8 | 12835699 | CpG motifs: the active ingredient in bacterial extracts? | Nat Med | 2003 | https://conductscience.org/library/papers/12835699 | PubMed |
| 9 | 12960338 | Toll-like receptor 4-mediated innate IL-10 activates antigen-specific regulatory T cells and confers resistance to Bordetella pertussis by inhibiting inflammatory pathology. | J Immunol | 2003 | https://conductscience.org/library/papers/12960338 | PubMed |
| 10 | 15876918 | Epidemiology of pertussis. | Pediatr Infect Dis J | 2005 | https://conductscience.org/library/papers/15876918 | PubMed |
| 11 | 15876927 | Duration of immunity against pertussis after natural infection or vaccination. | Pediatr Infect Dis J | 2005 | https://conductscience.org/library/papers/15876927 | PubMed |
| 12 | 16006019 | A CpG-containing oligodeoxynucleotide as an efficient adjuvant counterbalancing the Th1/Th2 immune response in diphtheria-tetanus-pertussis vaccine. | Vaccine | 2005 | https://conductscience.org/library/papers/16006019 | PubMed |
| 13 | 16818371 | Immune mechanisms and therapeutic potential of CpG oligodeoxynucleotides. | Int Rev Immunol | 2006 | https://conductscience.org/library/papers/16818371 | PubMed |
| 14 | 16863919 | Induction of dendritic cell maturation by pertussis toxin and its B subunit differentially initiate Toll-like receptor 4-dependent signal transduction pathways. | Exp Hematol | 2006 | https://conductscience.org/library/papers/16863919 | PubMed |
| 15 | 17114471 | TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells. | J Immunol | 2006 | https://conductscience.org/library/papers/17114471 | PubMed |
| 16 | 17116347 | Modulation of the infant immune responses by the first pertussis vaccine administrations. | Vaccine | 2007 | https://conductscience.org/library/papers/17116347 | PubMed |
| 17 | 17494641 | Lipopolysaccharide analogs improve efficacy of acellular pertussis vaccine and reduce type I hypersensitivity in mice. | Clin Vaccine Immunol | 2007 | https://conductscience.org/library/papers/17494641 | PubMed |
| 18 | 17920273 | The benefits of using diverse animal models for studying pertussis. | Trends Microbiol | 2007 | https://conductscience.org/library/papers/17920273 | PubMed |
| 19 | 18498620 | The role of Toll-like receptor-4 in pertussis vaccine-induced immunity. | BMC Immunol | 2008 | https://conductscience.org/library/papers/18498620 | PubMed |
| 20 | 18566386 | Lipopolysaccharides from Bordetella pertussis and Bordetella parapertussis differently modulate human dendritic cell functions resulting in divergent prevalence of Th17-polarized responses. | J Immunol | 2008 | https://conductscience.org/library/papers/18566386 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40709171 | Pertussis resurgence: epidemiological trends, pathogenic mechanisms, and preventive strategies. | Front Immunol | 2025 | https://conductscience.org/library/papers/40709171 | PubMed |
| 40475765 | Avidity of pertussis toxin antibodies following vaccination with genetically versus chemically detoxified pertussis toxin-containing vaccines during pregnancy. | Front Immunol | 2025 | https://conductscience.org/library/papers/40475765 | PubMed |
| 39233381 | Microbiota-immune-brain interactions: A new vision in the understanding of periodontal health and disease. | Periodontol 2000 | 2024 | https://conductscience.org/library/papers/39233381 | PubMed |
| 37651198 | DNA-Dependent Interferon Induction and Lung Inflammation in Bordetella pertussis Infection. | J Interferon Cytokine Res | 2023 | https://conductscience.org/library/papers/37651198 | PubMed |
| 37242993 | Coping Strategies for Pertussis Resurgence. | Vaccines (Basel) | 2023 | https://conductscience.org/library/papers/37242993 | PubMed |
| 36136586 | The whole-cell pertussis vaccine imposes a broad effector B cell response in mouse heterologous prime-boost settings. | JCI Insight | 2022 | https://conductscience.org/library/papers/36136586 | PubMed |
| 35269842 | Replication-Deficient Lymphocytic Choriomeningitis Virus-Vectored Vaccine Candidate for the Induction of T Cell Immunity against Mycobacterium tuberculosis. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35269842 | PubMed |
| 35222350 | Precision Vaccine Development: Cues From Natural Immunity. | Front Immunol | 2021 | https://conductscience.org/library/papers/35222350 | PubMed |
| 34097504 | Triggering Receptor Expressed on Myeloid Cells-1 (TREM-1) Contributes to Bordetella pertussis Inflammatory Pathology. | Infect Immun | 2021 | https://conductscience.org/library/papers/34097504 | PubMed |
| 33489011 | Structure and compositional analysis of aluminum oxyhydroxide adsorbed pertussis vaccine. | Comput Struct Biotechnol J | 2021 | https://conductscience.org/library/papers/33489011 | PubMed |
| 33228165 | Acellular Pertussis Vaccine Inhibits Bordetella pertussis Clearance from the Nasal Mucosa of Mice. | Vaccines (Basel) | 2020 | https://conductscience.org/library/papers/33228165 | PubMed |
| 32963814 | Expanding the role of bacterial vaccines into life-course vaccination strategies and prevention of antimicrobial-resistant infections. | NPJ Vaccines | 2020 | https://conductscience.org/library/papers/32963814 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IFNG | 3458 | PubTator's text mining | https://conductscience.org/library/genes/3458 | NCBI Gene |
| IL5 | 3567 | PubTator's text mining | https://conductscience.org/library/genes/3567 | NCBI Gene |
| TLR4 | 7099 | PubTator's text mining | https://conductscience.org/library/genes/7099 | NCBI Gene |
| TLR9 | 54106 | PubTator's text mining | https://conductscience.org/library/genes/54106 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31333656
GET https://conductscience.org/api/papers/v1/31333656/references?page=2